The Lewis and Faye Manderson Cancer Center at DCH Regional Medical Center has been awarded its third three-year accreditation with commendation from the Commission on Cancer (CoC) of the American College of Surgeons. This is the highest level of approval granted by the organization.
In order to receive the reaccreditation, the Cancer Center had had to exceed on 34 CoC quality care standards, be evaluated every three years through an on-site evaluation process and maintain levels of excellence in the delivery of comprehensive patient-centered care.
“As a CoC-accredited cancer center, the Manderson Cancer Center takes a multidisciplinary approach to treating cancer,” said Donna Marrero, vice president of outpatient and ancillary services for the DCH Health System. “We believe treating cancer requires consultation among surgeons, medical and radiation oncologists, diagnostic radiologists, pathologists and other cancer specialists.”
The CoC accreditation program provides the framework for the Manderson Cancer Center to improve its quality of patient care through programs that focus on the full spectrum of cancer care including prevention, early diagnosis, cancer staging, optimal treatment, rehabilitation, life-long follow-up for recurrent disease and end-of-life care.
Patients also have access to information on clinical trials and new treatments, genetic counseling and patient-centered services including psycho-social support, a patient navigation process and a survivorship care plan that documents the care each patient receives and seeks to improve cancer survivors’ quality of life, Marrero said.
Like all CoC-accredited facilities, the Manderson Cancer Center maintains a cancer registry and contributes data to the National Cancer Data Base, a joint program of the CoC and American Cancer Society. This nationwide oncology outcomes database is the largest clinical disease registry in the world.